Disease | neurofibromatosis |
Comorbidity | C0751690|malignant peripheral nerve sheath tumor |
Sentences | 19 |
PubMedID- 23161774 | There are conflicting reports as to whether malignant peripheral nerve sheath tumor (mpnst) patients with neurofibromatosis type 1 (nf1) have worse prognosis than non-nf1 mpnst patients. |
PubMedID- 23244685 | Molecular heterogeneity in malignant peripheral nerve sheath tumors associated with neurofibromatosis type 1. |
PubMedID- 24166582 | Benign whole body tumor volume is a risk factor for malignant peripheral nerve sheath tumors in neurofibromatosis type 1. |
PubMedID- 26018702 | Foreign body abscess mimicking a malignant peripheral nerve sheath tumor in a patient with neurofibromatosis type 1. |
PubMedID- 23483452 | We used genome-wide serum mirna expression analysis to investigate the role of serum mirnas in distinguishing malignant peripheral nerve sheath tumor (mpnst) patients with and without neurofibromatosis type 1 (nf1) from nf1 patients. |
PubMedID- 20205747 | malignant peripheral nerve sheath tumor associated with neurofibromatosis type 1, with metastasis to the heart: a case report. |
PubMedID- 23292448 | Since the bi-allelic inactivation of both neurofibromin 1 (nf1) gene alleles (nf1(-/-)) in schwann cells (scs) is common in both benign plexiform neurofibromas (pns) and malignant peripheral nerve sheath tumors (mpnsts) in patients with neurofibromatosis type 1 (nf1), other genetic alterations in scs may be required for tumor progression of pns to mpnsts. |
PubMedID- 22869071 | A novel nf1 mutation in a chinese patient with giant cafe-au-lait macule in neurofibromatosis type 1 associated with a malignant peripheral nerve sheath tumor and bone abnormality. |
PubMedID- 25317349 | malignant peripheral nerve sheath tumors in children with neurofibromatosis type 1. |
PubMedID- 22745048 | Metronomic therapy for malignant peripheral nerve sheath tumor in neurofibromatosis type 1. |
PubMedID- 23972085 | Chemotherapy for the treatment of malignant peripheral nerve sheath tumors in neurofibromatosis 1: a 10-year institutional review. |
PubMedID- 23047517 | Metastatic malignant peripheral nerve sheath tumor in neurofibromatosis type 1: a geriatric patient report. |
PubMedID- 23242059 | Purpose: the aim of this study was to compare the diagnostic performance of (1)(8)f-fluorodeoxyglucose (fdg) pet/ct and whole-body mri for the detection of malignant peripheral nerve sheath tumors (mpnsts) in patients with neurofibromatosis type 1, and to evaluate a panel of imaging-based criteria serving that purpose. |
PubMedID- 21731277 | Intraoral presentation of multiple malignant peripheral nerve sheath tumors associated with neurofibromatosis-1. |
PubMedID- 23101443 | Role of resection of malignant peripheral nerve sheath tumors in patients with neurofibromatosis type 1. |
PubMedID- 26445379 | Diagnostic accuracy of pet/ct-guided percutaneous biopsies for malignant peripheral nerve sheath tumors in neurofibromatosis type 1 patients. |
PubMedID- 20664435 | Conclusion: neurofibromatosis type 1 with malignant peripheral nerve sheath tumors complicating pregnancy requires an experienced, multidisciplinary team of care offering an aggressive evaluation to rule out malignant transformation or recurrence when there is any change in clinical status of a patient, as this may signal a potentially fatal change in the lesion. |
PubMedID- 20686424 | The role of angiogenesis in the transformation of plexiform neurofibroma into malignant peripheral nerve sheath tumors in children with neurofibromatosis type 1. |
PubMedID- 24343189 | malignant peripheral nerve sheath tumor in neurofibromatosis type 1. |
Page: 1